NASDAQ:AVGR - Avinger Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.46 -0.01 (-2.15 %) (As of 05/24/2019 04:00 PM ET)Previous Close$0.47Today's Range$0.4550 - $0.4752-Week Range$0.18 - $2.20Volume685,867 shsAverage Volume4.41 million shsMarket Capitalization$29.21 millionP/E RatioN/ADividend YieldN/ABeta1.93 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California. Receive AVGR News and Ratings via Email Sign-up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AVGR Previous Symbol CUSIPN/A CIK1506928 Webhttp://www.avinger.com/ Phone650-241-7900Debt Debt-to-Equity RatioN/A Current Ratio1.86 Quick Ratio1.56Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$7.91 million Price / Sales3.69 Cash FlowN/A Price / Cash FlowN/A Book Value$0.21 per share Price / Book2.17Profitability EPS (Most Recent Fiscal Year)($3.34) Net Income$-27,560,000.00 Net Margins-291.57% Return on Equity-276.71% Return on Assets-105.93%Miscellaneous EmployeesN/A Outstanding Shares64,195,000Market Cap$29.21 million Next Earnings Date8/12/2019 (Estimated) OptionableNot Optionable Avinger (NASDAQ:AVGR) Frequently Asked Questions What is Avinger's stock symbol? Avinger trades on the NASDAQ under the ticker symbol "AVGR." When did Avinger's stock split? How did Avinger's stock split work? Avinger shares reverse split before market open on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split. How were Avinger's earnings last quarter? Avinger Inc (NASDAQ:AVGR) issued its quarterly earnings results on Wednesday, May, 8th. The medical device company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by $0.01. The medical device company had revenue of $1.84 million for the quarter. Avinger had a negative net margin of 291.57% and a negative return on equity of 276.71%. View Avinger's Earnings History. When is Avinger's next earnings date? Avinger is scheduled to release their next quarterly earnings announcement on Monday, August 12th 2019. View Earnings Estimates for Avinger. Has Avinger been receiving favorable news coverage? News articles about AVGR stock have trended neutral recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Avinger earned a news impact score of 0.4 on InfoTrie's scale. They also assigned press coverage about the medical device company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the near term. Who are some of Avinger's key competitors? Some companies that are related to Avinger include Endologix (ELGX), iCAD (ICAD), Sensus Healthcare (SRTS), T2 Biosystems (TTOO), RenovaCare (RCAR), Apollo Endosurgery (APEN), Nuvectra (NVTR), Motus GI (MOTS), CAS Medical Systems (CASM), Repro-Med Systems (REPR), STRATA Skin Sciences (SSKN), RA Medical Systems (RMED), Titan Medical (TMDI), Pro-Dex (PDEX) and Invo Bioscience (IVOB). What other stocks do shareholders of Avinger own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avinger investors own include Check Cap (CHEK), AVEO Pharmaceuticals (AVEO), Micron Technology (MU), AcelRx Pharmaceuticals (ACRX), Denbury Resources (DNR), Palatin Technologies (PTN), Aralez Pharmaceuticals (ARLZ), Histogenics (HSGX), Alibaba Group (BABA) and Bellerophon Therapeutics (BLPH). Who are Avinger's key executives? Avinger's management team includes the folowing people: Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 57)Mr. Mark B. Weinswig, Chief Financial Officer (Age 46)Mr. Himanshu N. Patel, Chief Technology Officer (Age 59)Mr. Keith Schaefer, Chief Operating OfficerMr. Philip R. Preuss, VP of Marketing & Bus. Operations (Age 41) When did Avinger IPO? (AVGR) raised $60 million in an IPO on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers. Who are Avinger's major shareholders? Avinger's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Perkins Capital Management Inc. (3.56%), Renaissance Technologies LLC (2.20%), Jane Street Group LLC (0.37%), Spark Investment Management LLC (0.21%), Northern Trust Corp (0.08%) and Commonwealth Equity Services LLC (0.06%). Company insiders that own Avinger stock include Himanshu Patel and John B Ph D Md Simpson. View Institutional Ownership Trends for Avinger. Which major investors are selling Avinger stock? AVGR stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc.. View Insider Buying and Selling for Avinger. Which major investors are buying Avinger stock? AVGR stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Jane Street Group LLC, Spark Investment Management LLC, Northern Trust Corp and Commonwealth Equity Services LLC. View Insider Buying and Selling for Avinger. How do I buy shares of Avinger? Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Avinger's stock price today? One share of AVGR stock can currently be purchased for approximately $0.4550. How big of a company is Avinger? Avinger has a market capitalization of $29.21 million and generates $7.91 million in revenue each year. The medical device company earns $-27,560,000.00 in net income (profit) each year or ($3.34) on an earnings per share basis. What is Avinger's official website? The official website for Avinger is http://www.avinger.com/. How can I contact Avinger? Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected] MarketBeat Community Rating for Avinger (NASDAQ AVGR)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 288 (Vote Outperform)Underperform Votes: 250 (Vote Underperform)Total Votes: 538MarketBeat's community ratings are surveys of what our community members think about Avinger and other stocks. Vote "Outperform" if you believe AVGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVGR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: How to Invest in a Bull Market Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.